ABBOTT LABORATORIES — Director's Dealing 2015

Jun 6, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2015-06-03

Reporting Person: Pavee Jean-Yves (Senior Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-06-03	Common shares without par value	M	5200	$25.2461	Acquired	30806	Direct
2015-06-03	Common shares without par value	M	5300	$26.6973	Acquired	36106	Direct
2015-06-03	Common shares without par value	S	10500	$49	Disposed	25606	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-06-03	Option (right to buy)	$25.2461	M	5200	Disposed	2017-02-15	Common shares (5200)	Direct
2015-06-03	Option (right to buy)	$26.6973	M	5300	Disposed	2018-02-14	Common shares (5300)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	2711	Indirect
Common shares without par value	2966	Indirect
Common shares without par value	2967	Indirect
Common shares without par value	2966	Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of June 4, 2015.

F2: The reporting person disclaims beneficial ownership of all securities held by his daughter.

F3: The reporting person disclaims beneficial ownership of all securities held by his son.

F4: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.